arrow
A

Asier Sáez-Cirión

université parís cité
H指数:41
被引数:6,820

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Constitutive natural killer cell features associated with post-treatment control of SIV infection in the pVISCONTI study

pVISCONTI研究中与治疗后控制SIV感染相关的固有自然杀伤细胞特征

2026-08-220
OAAI
Post-treatment SIV control is associated with specific features of viral persistence before and after treatment interruption

治疗后SIV控制与治疗前及治疗中断后的病毒持续存在特征相关

2026-02-270
OAAI
The imperative for increased investment for an HIV cure

加大投资以寻求艾滋病治愈的必要性

2025-07-220
PRE
A genetic fingerprint associated with durable HIV remission after interruption of antiretroviral treatment: ANRS VISCONTI/PRIMO

与抗逆转录病毒治疗中断后持久HIV缓解相关的遗传指纹:ANRS VISCONTI/PRIMO

Med
IF11.8
2025-04-280
OAAI
Sustained HIV remission after allogeneic hematopoietic stem cell transplantation with wild-type CCR5 donor cells
2024-09-024
PRE
Distinct SIV-specific CD8+ T cells in the lymph node exhibit simultaneous effector and stem-like profiles and are associated with limited SIV persistence
2024-06-176
PRE
Early antiretroviral therapy favors post-treatment SIV control associated with the expansion of enhanced memory CD8+ T-cells

早期抗逆转录病毒治疗有利于与增强的记忆CD8 T细胞扩增相关的治疗后SIV控制

2024-01-1114
OAAI
CD8+ T-cell priming is quantitatively but not qualitatively impaired in people with HIV-1 on antiretroviral therapy

在接受抗逆转录病毒治疗的HIV-1患者中,CD8 T细胞启动在数量上受损,但在质量上没有受损

AIDS
IF3.1
2023-10-050
OA
In-depth virological and immunological characterization of HIV-1 cure after CCR5Δ32/Δ32 allogeneic hematopoietic stem cell transplantation
2023-02-2086
OAAI
Autopsy Study Defines Composition and Dynamics of the HIV-1 Reservoir after Allogeneic Hematopoietic Stem Cell Transplantation with CCR5Δ32/Δ32 Donor Cells

尸检研究定义了CCR5Δ32/Δ32供体细胞异基因造血干细胞移植后HIV-1库的组成和动力学

2022-09-176
OAAI
Reprogramming dysfunctional CD8+ T cells to promote properties associated with natural HIV control

重新编程功能失调的CD8 T细胞以促进与自然HIV控制相关的特性

2022-06-0115
OAAI
Novel role of UHRF1 in the epigenetic repression of the latent HIV-1

UHRF1在潜在HIV-1的表观遗传抑制中的新作用

2022-05-0114
OAAI